Antonius W.M. Boersma

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Herman Burger, Hans van Tol, Antonius W.M. Boersma et al. · Blood · 2004 · 412 citations · Full text

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

John A. Foekens, Anieta M. Sieuwerts, Marcel Smid et al. · Proceedings of the National Academy of Sciences · 2008 · 365 citations · Full text

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

Muhammad Riaz, Marijn TM van Jaarsveld, Antoinette Hollestelle et al. · Breast Cancer Research · 2013 · 225 citations · Full text

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

Marijn T. M. van Jaarsveld, Jozien Helleman, Antonius W.M. Boersma et al. · Oncogene · 2012 · 218 citations

Cisplatin Sensitivity, Medicine, Mir-141 Regulates Keap1 +10

Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin

Antonius W.M. Boersma, Kees Nooter, Robert Oostrum et al. · Cytometry · 1996 · 151 citations

Oocyte, Immunocytochemical Technique, Apoptosis +16